Predictive value of clinicopathological markers for the metachronous bladder cancer and prognosis of upper tract urothelial carcinoma

Scientific Reports

Volumn 4, Issue , 2014, Pages

  Feng, Chenchen ^a   Wang, Lujia ^a   Ding, Guanxiong ^a   Ding, Qiang ^a   Zhou, Zhongwen ^b   Jiang, Haowen ^a   Wu, Zhong ^a  

^a Department of Urology ^*  (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53; TUMOR MARKER;

ADULT; AGED; ARTICLE; BIOSYNTHESIS; BLADDER TUMOR; FEMALE; HEMATURIA; HUMAN; KIDNEY; MALE; MIDDLE AGED; MORTALITY; PATHOLOGY; PROGNOSIS; RETROSPECTIVE STUDY; SECOND CANCER; TREATMENT OUTCOME; TUMOR RECURRENCE; URETER; URETER TUMOR; UROTHELIUM; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; HEMATURIA; HUMANS; KI-67 ANTIGEN; KIDNEY; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SECOND PRIMARY; PROGNOSIS; RETROSPECTIVE STUDIES; TREATMENT OUTCOME; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53; URETER; URETERAL NEOPLASMS; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 84893820909     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep04015     Document Type: Article

References (42)

1. Munoz, J. J. &Ellison, L. M. Upper tract urothelial neoplasms: incidence and survival during the last 2 decades. J Urol 164, 1523-5 (2000)
2. Ploeg, M.,Aben,K. K.&Kiemeney, L. A. The present and future burden of urinary bladder cancer in the world. World J Urol 27, 289-93 (2009)
3. Roupret, M. et al. European guidelines for the diagnosis and management of upper urinary tract urothelial cell carcinomas: 2011 update. Eur Urol 59, 584-94 (2011)
4. Siegel, R.,Naishadham,D.&Jemal, A. Cancer statistics, 2012. CA Cancer J Clin 62, 10-29 (2012)
5. Babjuk, M. et al. EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder, the 2011 update. Eur Urol 59, 997-1008 (2011)
6. Margulis, V. et al. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115, 1224-33 (2009)
7. Abouassaly, R. et al. Troubling outcomes from population-level analysis of surgery for upper tract urothelial carcinoma. Urology 76, 895-901 (2010)
8. Jeldres, C. et al. A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma. Urology 75, 315-20 (2010)
9. Brien, J. C. et al. Preoperative hydronephrosis, ureteroscopic biopsy grade and urinary cytology can improve prediction of advanced upper tract urothelial carcinoma. J Urol 184, 69-73 (2010)
10. Eltz, S., Comperat, E., Cussenot, O. &Roupret, M. Molecular and histological markers in urothelial carcinomas of the upper urinary tract. BJU Int 102, 532-5 (2008)
11. Comperat, E. et al. Prognostic value of MET, RONand histoprognostic factors for urothelial carcinoma in the upper urinary tract. JUrol 179, 868-72; discussion 872 (2008)
12. Scarpini, S. et al. Impact of the expression of Aurora-A, p53, and MIB-1 on the prognosis of urothelial carcinomas of the upper urinary tract. Urol Oncol 30, 182-7 (2012)
13. Kosaka, T. et al. Expression of snail in upper urinary tract urothelial carcinoma: prognostic significance and implications for tumor invasion. Clin Cancer Res 16, 5814-23 (2010)
14. Roupret, M. et al. European guidelines on upper tract urothelial carcinomas: 2013 update. Eur Urol 63, 1059-71 (2013)
15. Vet, J. A. et al. p53 mutations have no additional prognostic value over stage in bladder cancer. Br J Cancer 70, 496-500 (1994)
16. Erill, N. et al. Genetic and immunophenotype analyses of TP53 in bladder cancer: TP53 alterations are associated with tumor progression. Diagn Mol Pathol 13, 217-23 (2004) (Pubitemid 39552243)
17. Yurakh, A. O. et al. Molecular and immunohistochemical analysis of the prognostic value of cell-cycle regulators in urothelial neoplasms of the bladder. Eur Urol 50, 506-15; discussion 515 (2006) (Pubitemid 44189058)
18. Wang, L. et al. Ki67 and TP53 expressions predict recurrence of non-muscleinvasive bladder cancer. Tumour Biol. [Epub] DOI: 10.1007/s13277-013- 1384-9 (2013)
19. Wang, L. et al. Relationship of TP53 and Ki67 expression in bladder cancer under WHO 2004 classification. J BUON 18, 420-4 (2013)
20. Krabbe, L. M. et al. Prospective comparison of molecular signatures in urothelial cancer of the bladder and the upper urinary tract: is there evidence for discordant biology? J Urol. [Epub] DOI: 10.1016/j.juro.2013.09.031 (2013)
21. Sauter, G. et al. [Tumours of the urinary system: non-invasive urothelial neoplasias] WHO classification of classification of tumours of the urinary system and male genital organs [Eble, J. N., Sauter, G., Epstein, J. l., Sesterhenn, I. (eds)]. (IARCC Press, Lyon, 2004)
22. Sobin, L. et al. [Renal Pelvis and ureter] TNM classification of malignant tumors. Urological tumors. International Union Against Cancer. (Wiley-Blackwell, New York, 2009)
23. Ouzzane, A. et al. Ureteral and multifocal tumours have worse prognosis than renal pelvic tumours in urothelial carcinoma of the upper urinary tract treated by nephroureterectomy. Eur Urol 60, 1258-65 (2011)
24. Chromecki, T. F. et al. The impact of tumor multifocality on outcomes in patients treated with radical nephroureterectomy. Eur Urol 61, 245-53 (2012)
25. Feng, C.-c. et al. Pigment epithelium-derived factor expression is down-regulated in bladder tumors and correlates with vascular endothelial growth factor and matrix metalloproteinase-9. International urology and nephrology 43, 383-390 (2011)
26. Feng, C. C. et al. [Urinary BLCA-4 level is useful to detect upper urinary tract urothelial cell carcinoma]. Actas Urol Esp 36, 597-602 (2012)
27. Cho, D. S., Hong, S. Y., Kim, Y. K., Kim, S. I. &Kim, S. J. Prognostic factors in transitional cell carcinoma of the upper urinary tract after radical nephroureterectomy. Korean J Urol 52, 310-6 (2011)
28. Jeldres, C. et al. Highly predictive survival nomogram after upper urinary tract urothelial carcinoma. Cancer 116, 3774-84 (2010)
29. Margulis, V. et al. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184, 453-8 (2010)
30. Verhoest, G. et al. Predictive factors of recurrence and survival of upper tract urothelial carcinomas. World J Urol 29, 495-501 (2011)
31. Kikuchi, E. et al. Lymphovascular invasion predicts clinical outcomes in patients with node-negative upper tract urothelial carcinoma. J Clin Oncol 27, 612-8 (2009)
32. Bagrodia, A. et al. Prospective evaluation of molecular markers for the staging and prognosis of upper tract urothelial carcinoma. Eur Urol 62, e27-9 (2012)
33. Rey, A., Lara, P. C., Redondo, E., Valdes, E. &Apolinario, R. KI67 proliferation index in tumors of the upper urinary tract as related to established prognostic factors and long-term survival. Arch Esp Urol 51, 204-10 (1998)
34. Kojima, K., Naruo, S., Kanayama, H. &Kagawa, S. [Evaluation of Ki67 antigen using MIB1 antibody as a prognostic factor in renal pelvic and ureteral cancer]. Nihon Hinyokika Gakkai Zasshi 87, 822-30 (1996)
35. Kamijima, S. et al. The prognostic value of p53, Ki-67 and matrix metalloproteinases MMP-2 and MMP-9 in transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 12, 941-7 (2005) (Pubitemid 43110228)
36. Sanchez-Ortiz, R. F. et al. An interval longer than 12 weeks between the diagnosis of muscle invasion and cystectomy is associated with worse outcome in bladder carcinoma. J Urol 169, 110-5; discussion 115 (2003) (Pubitemid 35461564)
37. Sundi, D. et al. Upper tract urothelial carcinoma: impact of time to surgery. Urol Oncol 30, 266-72 (2012)
38. Ku, J. H. et al. The Role of p53 on Survival of Upper Urinary Tract Urothelial Carcinoma: A Systematic Review and Meta-Analysis. Clin Genitourin Cancer 11, 221-8 (2013)
39. Hashimoto, H., Sue, Y., Saga, Y., Tokumitsu, M. &Yachiku, S. Roles of p53 and MDM2 in tumor proliferation and determination of the prognosis of transitional cell carcinoma of the renal pelvis and ureter. Int J Urol 7, 457-63 (2000) (Pubitemid 32108394)
40. Xylinas, E. et al. Multifocal carcinoma in situ of the upper tract is associated with high risk of bladder cancer recurrence. Eur Urol 61, 1069-70 (2012)
41. Novara, G. et al. Independent predictors of metachronous bladder transitional cell carcinoma (TCC) after nephroureterectomy for TCC of the upper urinary tract. BJU Int 101, 1368-74 (2008) (Pubitemid 351623978)
42. Zigeuner, R. E., Hutterer, G., Chromecki, T., Rehak, P. &Langner, C. Bladder tumour development after urothelial carcinoma of the upper urinary tract is related to primary tumour location. BJU Int 98, 1181-6 (2006)